Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash And Cash Equivalents $ 17,819,044 $ 20,303,869
Other Current Assets 193,635 217,745
Total Current Assets 18,012,679 20,521,614
Operating Lease Right-of-use Asset 53,694 0
Total Assets 18,066,373 20,521,614
Current Liabilities:    
Accounts Payable, Accrued Expenses And Other Current Liabilities 1,074,124 1,580,543
Total Current Liabilities 1,074,124 1,580,543
Non-current Operating Lease Liability 25,338 0
Total Liabilities 1,099,462 1,580,543
Stockholders Equity    
Common Stock, Par Value Of $0.001 Per Share, 40,000,000 Shares Authorized, 12,620,592 And 12,598,125 Shares Issued And Outstanding At March 31, 2022, And December 31, 2021, Respectively 12,621 12,598
Additional Paid-in Capital 60,703,139 60,220,016
Accumulated Other Comprehensive Loss (3,744) (3,160)
Accumulated Deficit (43,745,105) (41,288,383)
Total Stockholders' Equity 16,966,911 18,941,071
Total Liabilities And Stockholders' Equity $ 18,066,373 $ 20,521,614